Virta Health

Virta Health is a telehealth company with a specific clinical mission: type 2 diabetes reversal through a ketogenic diet intervention supported by continuous remote care. Founded in 2014 and peer-reviewed in multiple clinical publications, Virta's clinical model uses a very low-carbohydrate diet combined with real-time biometric monitoring (blood glucose, ketones, weight) and frequent physician and health coach contact to safely reduce or eliminate diabetes medications in eligible patients. Virta's outcome data shows that a majority of patients who complete the program achieve type 2 diabetes reversal (HbA1c below diabetic threshold without medication) or significant improvement — results that significantly exceed standard care. The program is medically supervised, with physicians adjusting medications in real time as blood glucose improves, which requires closer oversight than lifestyle programs that do not involve medication management. Virta works primarily through employer health plans and insurance, though direct enrollment is available. The $400/month program fee is substantial but is often covered by employer benefits, Medicare Advantage, and Medicaid in select states, and is offset by reduced medication costs for patients who achieve reversal. Virta is not a GLP-1 program — it does not prescribe semaglutide or tirzepatide. It is a dietary intervention for patients whose diabetes may be reversible through carbohydrate restriction. weight) and frequent physician and health coach contact to safely reduce or eliminate diabetes medications in eligible patients. Virta's outcome data shows that a majority of patients who complete the program achieve type 2 diabetes reversal (HbA1c below diabetic threshold without medication) or significant improvement — results that significantly exceed standard care. The program is medically supervised, with physicians adjusting medications in real time as blood glucose improves, which requires closer oversight than lifestyle programs that do not involve medication management. Virta works primarily through employer health plans and insurance, though direct enrollment is available. The $400/month program fee is substantial but is often covered by employer benefits, Medicare Advantage, and Medicaid in select states, and is offset by reduced medication costs for patients who achieve reversal. Virta is not a GLP-1 program — it does not prescribe semaglutide or tirzepatide. It is a dietary intervention for patients whose diabetes may be reversible through carbohydrate restriction.